We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+0.73%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$24.1B
AUM Growth
+$1.97B
(+8.9%)
Cap. Flow
+$2.05B
Cap. Flow
% of AUM
8.49%
Top 10 Holdings %
Top 10 Hldgs %
10.49%
Holding
3,709
New
1,118
Increased
953
Reduced
622
Closed
747
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Uber
UBER
|
+$127M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$126M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$122M |
| 4 |
SkinHealth Systems
SKIN
|
+$90.5M |
| 5 |
Advanced Micro Devices
AMD
|
+$81.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$210M |
| 2 |
PARA
Paramount Global Class B
PARA
|
+$187M |
| 3 |
XYZ
Block Inc
XYZ
|
+$111M |
| 4 |
Danaher
DHR
|
+$109M |
| 5 |
Monster Beverage
MNST
|
+$101M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.28% |
| 2 | Financials | 16.56% |
| 3 | Technology | 13.74% |
| 4 | Consumer Discretionary | 11.01% |
| 5 | Communication Services | 4.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VSTA
2551
DELISTED
Vasta Platform
VSTA
| $362K | ﹤0.01% |
79,221
-27,242
| -26% | -$171K |
|
2552
CALL
Wells Fargo
WFC
$254B
| $362K | ﹤0.01% |
+7,800
| New | +$361K |
|
|
ORTX
2553
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $361K | ﹤0.01% |
+15,719
| New | +$468K |
|
2554
CALL
Japer Therapeutics Warrants
JSPRW
$182K
| $359K | ﹤0.01% |
+35,015
| New | +$37.4K |
|
2555
Northern Trust
NTRS
$21.8B
| $359K | ﹤0.01% |
3,329
-18,155
| -85% | -$2.06M |
|
2556
Tiptree Inc
TIPT
$687M
| $359K | ﹤0.01% |
35,919
-72,885
| -67% | -$713K |
|
2557
Dyne Therapeutics
DYN
$4.68B
| $358K | ﹤0.01% |
22,052
| – | – |
|
2558
Carriage Services
CSV
$647M
| $357K | ﹤0.01% |
8,010
-43,808
| -85% | -$1.77M |
|
2559
PUT
iShares Biotechnology ETF
IBB
$9.45B
| $356K | ﹤0.01% |
2,200
-21,800
| -91% | -$3.67M |
|
2560
Addus HomeCare
ADUS
$2.22B
| $355K | ﹤0.01% |
4,457
-31,345
| -88% | -$2.72M |
|
2561
InnovAge Holding
INNV
$1.56B
| $355K | ﹤0.01% |
+53,773
| New | +$833K |
|
2562
PepsiCo
PEP
$196B
| $355K | ﹤0.01% |
2,356
-19,701
| -89% | -$3.05M |
|
2563
PUT
Starbucks
SBUX
$119B
| $353K | ﹤0.01% |
+3,200
| New | +$375K |
|
|
SNCY
2564
DELISTED
Sun Country Airlines
SNCY
| $353K | ﹤0.01% |
+10,519
| New | +$350K |
|
2565
Western Digital
WDC
$159B
| $351K | ﹤0.01% |
8,226
-120,399
| -94% | -$5.72M |
|
|
DISH
2566
DELISTED
DISH Network Corp.
DISH
| $351K | ﹤0.01% |
+8,078
| New | +$344K |
|
2567
iShares S&P 100 ETF
OEF
$19.5B
| $350K | ﹤0.01% |
+1,772
| New | +$360K |
|
2568
Goodyear
GT
$2.09B
| $349K | ﹤0.01% |
+19,728
| New | +$320K |
|
2569
Immuneering
IMRX
$262M
| $349K | ﹤0.01% |
+13,149
| New | +$353K |
|
2570
Cabot Corp
CBT
$4.72B
| $347K | ﹤0.01% |
+6,932
| New | +$370K |
|
2571
Altria Group
MO
$125B
| $347K | ﹤0.01% |
7,626
-50,417
| -87% | -$2.43M |
|
2572
Simon Property Group
SPG
$76.4B
| $347K | ﹤0.01% |
2,669
-51,495
| -95% | -$6.7M |
|
2573
PUT
Adobe
ADBE
$105B
| $345K | ﹤0.01% |
600
-700
| -54% | -$441K |
|
|
STKL
2574
DELISTED
SunOpta
STKL
| $345K | ﹤0.01% |
+38,632
| New | +$390K |
|
2575
CLPS Inc
CLPS
$26M
| $343K | ﹤0.01% |
118,652
-25,070
| -17% | -$88.1K |
|
Similar funds
Marshall Wace's Q3 2021 Portfolio in Review
As of Q3 2021, Marshall Wace held 3,709 positions worth $24.1B, up 8.9% from $22.1B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Marshall Wace deployed $2.05B of net new capital in Q3 2021, opening 1,118 new positions and adding to 953 existing holdings. Its largest new stake was SkinHealth Systems: 4,113,430 shares worth $107M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Biogen, an estimated $210M trimmed.
- Marshall Wace's largest Q3 2021 buy was SkinHealth Systems: 4,113,430 shares worth $107M.
- Marshall Wace added most to Uber in Q3 2021, an estimated $127M increase.
- Marshall Wace's biggest Q3 2021 reduction was Biogen, cutting an estimated $210M.
- Marshall Wace fully exited Vipshop in Q3 2021, selling an estimated $58.7M.
- Marshall Wace's ten largest holdings make up 10% of its $24.1B portfolio in Q3 2021.
- Marshall Wace opened 1,118 new positions and closed 747 in Q3 2021.
- Marshall Wace's portfolio value rose 8.9% quarter-over-quarter to $24.1B.
Based on Marshall Wace's 13F filing for Q3 2021, filed 15 Nov 2021.